Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
11/2010
11/03/2010CN101875611A Separation method of glyphosate mother solution
11/03/2010CN101270132B Method for preparing triphenylphosphine with diphenylbenzene phosphine oxide
11/03/2010CN101044148B Method for producing phosphonate having alcoholic hydroxy group
11/02/2010US7825274 Preparation of 10,10'-Phenylenedicarbonylbis(9-oxa-10-phosphaphenanthrene-10-oxide) by reacting excess PCl3 with o-phenylphenol to form 10-chloro-9,10-dihydro-9-oxa-10- phosphaphenanthrene; hydrolysis to form the phosphine oxide; and coupling with phthaloyl, isophthaloyl, or terephthaloyl chloride
11/02/2010US7825270 from soybean lecithins; solvent extraction; phytoglycolipid free; 1D-1-(1,2-di-O-fattyacyl-sn-glycero-3-phospho)-myo-inositol; for prophylaxis and treatment of diseases related to aberrant cellular and nuclear signaling; drug design, delivery
11/02/2010US7825260 (R)-2-amino-4-(2-benzo[1,3]dioxol-5-yl-benzoxazol-5-yl)-2-methyl-butan-1-ol; for the treatment or prevention of allo- or xenograft acute or chronic rejection or inflammatory or autoimmune disorders, or as a chemotherapeutic agent, e.g a malignant cell anti-proliferative agent
11/02/2010US7825250 Binuclear metal complex, metal complex dye, photoelectric conversion element, and photochemical battery
11/02/2010US7825238 Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine
10/2010
10/30/2010CA2668580A1 Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
10/28/2010WO2010123747A1 Highly selective process for producing organodiphosphites
10/28/2010WO2010123743A1 Highly selective process for producing organodiphosphites
10/28/2010WO2010122504A1 Thiazole derivatives and their use as p2y12 receptor antagonists
10/28/2010WO2010121774A1 Process for the production of cyanic acid c,c'-[2-(6-oxido-6h-dibenz[c,e][1,2]oxa-phosphorin-6-yl)-1,4-phenylene] ester
10/28/2010WO2010121387A1 Polymer nanoparticles
10/28/2010WO2010076995A9 Novel phosphonate based compound and flame retardant styrenic resin composition including the same
10/28/2010US20100273745 Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors
10/28/2010US20100273744 Compounds
10/28/2010US20100273742 Pharmacologically Active Agents Containing Esterified Phosphonates and Methods for Use Thereof
10/28/2010US20100273724 Pegylated ion channel modulating compounds
10/28/2010US20100270197 Multipurpose packages for sterile products or products to be sterilised
10/28/2010CA2756654A1 Thiazole derivatives and their use as p2y12 receptor antagonists
10/27/2010EP2243763A2 A selective synthesis of organophosphites
10/27/2010EP2243539A2 Functionalized ionic liquids, and methods of use thereof
10/27/2010EP2242760A1 Sulfonated organophosphine compounds and use in hydroformylation processes
10/27/2010EP1658282B1 Novel chelating agents and chelates and their use
10/27/2010CN101874034A Compounds and methods for the treatment of cancer
10/27/2010CN101870870A Phosphonate flame retardant and preparation method thereof
10/27/2010CN101870731A Polyclone antibody of H-9201, and preparation method and application thereof
10/27/2010CN101870713A Industrial production process for tenofovir disoproxil fumarate
10/27/2010CN101870712A Production method of dimethyl phosphite
10/27/2010CN101870711A Synthesis method of tris(trimethylsilyl) phosphate
10/26/2010US7820845 Reacting phosphorus trihalides and/or phosphorus-oxyhalides with alkylene oxides; flame retardants in polyurethanes; tris(chloropropyl) phosphate
10/26/2010US7820831 Compounds comprising a thiocarbonyl-sulfanyl group which can be used for the radical synthesis of α-perfluoroalkylamine compounds
10/26/2010US7820827 3,4-disubstituted-4-aryl-piperidine; treating pain with opioids while avoiding side effects such as constipation, nausea and vomiting by administering said compounds; treating gastrointestinal disorders such as ileus (bowel obstruction)
10/26/2010US7820822 fac-tris[7,7-difluoro-7H-dibenzo[de,h]quinoline-C2,N]iridium(III) (Ir1)A: 7,7-Difluorodibenzo[de,h]quinoline; use in organic electronic devices such as electroluminescent elements, and to their use in displays based thereon
10/26/2010US7820814 Inhibitors of kinases
10/26/2010US7820703 enhancing wound repair; treating reperfusion type injury; lyso-lipid phosphate phosphatase inhibitor; phosphoric acid mono-[3-(4-phenyloxy-pyrimidine)-2-octadec-9-enoylamino-propyl] ester or salt
10/26/2010US7820627 with core structure of pentaerythritol used as replacement for sugars; immunomodulators; immunogens within liposomes; tumor antigens; for use as haptens, inhibitors of bacterial-host cell adhesion; septic shock
10/26/2010CA2486415C Amorphous solid modification of bis(2,4-dicumylphenyl) pentaerythritol diphosphite
10/26/2010CA2289408C Corrosion inhibitor compositions
10/26/2010CA2133323C Self-assembling polynucleotide delivery system
10/21/2010US20100267991 Highly selective process for producing organodiphosphites
10/21/2010US20100267990 Highly selective process for producing organodiphosphites
10/21/2010US20100267980 Curing accelerator for deep-ultraviolet-transmitting epoxy resin, deep-ultraviolet-transmitting epoxy resin composition, and deep-ultraviolet-transmitting epoxy resin cured product
10/21/2010US20100267956 Chiral tridentate compounds, corresponding organometal complexes, method for preparing same and use of said compounds and complexes as ligands in asymmetrical catalysis
10/21/2010US20100267946 Prodrugs of gaba analogs, compositions and uses thereof
10/21/2010US20100267871 Organophosphonate oligomers
10/21/2010US20100267674 Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
10/21/2010US20100267673 Protein phosphatase 2a-activating agents
10/21/2010US20100267672 Novel compounds of reverse-turn mimetics, method for manufacturing the same and use thereof
10/21/2010CA2758823A1 Protein phosphatase 2a-activating agents
10/21/2010CA2758245A1 Gamma-amino-butyric acid derivatives as gabab receptor ligands
10/20/2010EP2241548A1 Vanadium di-nuclear complex
10/20/2010EP2241547A1 Method for producing aromatic compound polymer
10/20/2010EP2240502A1 Phosphonium ionic liquids and coatings made therefrom
10/20/2010EP2240501A1 Hydroxy-bisphosphonic acid derivatives as vector for targeting bone tissue
10/20/2010EP2240500A1 Method for synthesizing hydroxy-bisphosphonic acid derivatives
10/20/2010EP2240499A1 Diaryl alkylphosphonates and methods for preparing same
10/20/2010EP2240498A1 Production of lithium diphenylphosphide
10/20/2010EP2240435A2 Reagents and methods for the beta-keto amide synthesis of a synthetic precursor to immunological adjuvant e6020
10/20/2010EP2038241B1 Electroluminescent polymers and use thereof
10/20/2010CN101868469A Phosphonic acid derivates and their use as P2Y12 receptor antagonists
10/20/2010CN101868468A Bidentate secondary phosphine oxide chiral ligands for use in asymmetric addition reactions
10/20/2010CN101863958A Induction of the mitochondrial permeability transition
10/20/2010CN101863923A Novel inhibitors of chymase
10/20/2010CN101863922A Preparation method of polyether aromatic phosphine oxide midbody monomer with three functional groups
10/20/2010CN101863921A Organic/inorganic composite lamellar compound with regularly arranged triphenylphosphine and preparation method thereof
10/20/2010CN101863920A Method for preparing diethyl ethylphosphate
10/20/2010CN101863919A Preparation method of compound sodium ibandronate
10/20/2010CN101863918A Water-soluble dipropofol and preparation method thereof
10/20/2010CN101863917A Methocarbamol salt
10/20/2010CN101863788A 5-aminolevulinic acid phosphate salt, process for producing the same and use thereof
10/20/2010CN101863758A Technology for preparing ferulic acid and phytic acid from rice bran
10/20/2010CN101862665A Preparation of metal carbide on carriers and use of metal carbide as N-(Phosphonomethyl) iminodiacetic acid oxidation catalyst
10/19/2010US7816548 Method of preparing a hydrocarbylated metal-organic compound
10/19/2010US7816525 Process for the preparation of optically pure tetrahydropterins and derivatives, and specifically of optically pure tetrahydrofolic acid and derivatives thereof, by stereospecific hydrogenation
10/19/2010US7816398 Fatty alcohol drug conjugates
10/19/2010US7816379 Antibiotics with improved solubility, lower toxicity; potent antibacterial activity; includes torezolid phosphate
10/19/2010US7816345 Phosphorus-containing prodrugs
10/19/2010CA2411590C Glycopeptide phosphonate derivatives
10/19/2010CA2379988C Enzyme catalyzed therapeutic activation
10/19/2010CA2271096C Trisresorcinyltriazines
10/14/2010WO2010118309A2 Inhibitors of stat3 and uses thereof
10/14/2010WO2010118009A1 Hcv inhibitor and therapeutic agent combinations
10/14/2010WO2010116132A2 Bisphosphonate compounds for chelating radionuclides
10/14/2010WO2010115869A1 Propofol phosphonyl derivatives, synthesis, and use in long acting formulations
10/14/2010WO2010115854A1 Electronic devices comprising novel phosphonic acid surface modifiers
10/14/2010WO2010080396A3 Composition and method to provide stain release and stain repellency properties to substrates
10/14/2010US20100261926 Surface-modified nanodiamond and its producing method
10/14/2010US20100261903 Phosphonate fluorescent dyes and conjugates
10/14/2010US20100261681 Alpha-chloro and alpha-bromo phosphonate analogs of lysophosphatidic acid and methods of making and using thereof
10/14/2010US20100261678 Phosphonic acid derivates ad their use as p2y12 receptor antagonists
10/14/2010US20100261677 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions
10/14/2010US20100261676 Use of an Endogenous Ligand for Peroxisome Proliferator Activated Receptor Alpha to Treat Liver Disorders
10/14/2010US20100261674 Therapeutic applications of fatty acid amide hydrolase inhibitors
10/14/2010US20100261673 Antibacterial compounds and methods of using same
10/14/2010US20100261231 Dinucleotide MRNA CAP Analogs
10/13/2010EP2239266A1 Amorphous phosphite compound and method for its production
10/13/2010EP2239265A1 Crystalline cinnamide compounds or salts thereof
10/13/2010EP2239248A2 A selective synthesis of organophosphites
1 ... 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 ... 554